Flumarc en es it fr

Flumarc Brand names, Flumarc Analogs

Flumarc Brand Names Mixture

  • No information avaliable

Flumarc Chemical_Formula


Flumarc RX_link


Flumarc fda sheet

Flumarc FDA

Flumarc msds (material safety sheet)

Flumarc Synthesis Reference

M. Winn et al., U.S. Pat. 4,026,894 (1977)

Flumarc Molecular Weight

387.433 g/mol

Flumarc Melting Point

273 oC

Flumarc H2O Solubility


Flumarc State


Flumarc LogP


Flumarc Dosage Forms


Flumarc Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.

Flumarc Pharmacology

Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.

Flumarc Absorption

Essentially completely absorbed in man (90% bioavailability).

Flumarc side effects and Toxicity

LD50=259.3mg/kg (i.v. in mice)

Flumarc Patient Information

Flumarc Organisms Affected

Humans and other mammals